October 15, 2010
Titan Pharma Highlights Phase 3 Opioid Dependence Data in JAMA
Data from a previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were unveiled by Titan Pharmaceuticals, Inc.
Data from a previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were unveiled by Titan Pharmaceuticals, Inc.
Leave a Comment